News Sentiment

EVH sentiment intelligence

Evolent Health Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 64 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 5.88 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 64

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+3.0% over one week, +22.5% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 3.0% Price confirming higher
Trend fit Trend active 22.5% over four weeks
Fair value -63.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 48
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 64
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 22
Market source 8
Sahm 6
StockStory 5
TradingView 3
MT Newswires 2
The Globe and Mail 2
PR Newswire 2

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 18
Analyst action 5
Balance sheet 2
Macro sensitivity 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 64
Sahm Direct company coverage

Evolent Health (EVH) Narrows Q1 Loss To US$26.6 Million Testing Bullish Margin Narratives

Evolent Health (EVH) reported a Q1 2026 net loss of US$26.6 million on US$496.2 million in revenue, narrowing its loss from the previous quarter but still operating in loss-making territory. Analysts anticipate significant long-term margin improvement and profit, heavily relying

Tone
Neutral 50/100
Event
Earnings
Published
09 May 2026 01:39
Source
Sahm
Stock Titan Direct company coverage

Evolent Health (NYSE: EVH) trims Q1 2026 loss as revenue tops $496M

Evolent Health (NYSE: EVH) reported a narrower net loss of $26.6 million for Q1 2026, a significant improvement from the $72.3 million loss in Q1 2025, with revenue climbing to $496.2 million. The company's basic and diluted loss per share decreased to $0.24, compared to $0.63 in

Tone
Positive 62/100
Event
Earnings
Published
07 May 2026 12:39
Source
Stock Titan
Stock Titan Direct company coverage

Evolent (NYSE: EVH) trims Q1 2026 loss as costs rise, keeps outlook

Evolent Health, Inc. reported slightly increased Q1 2026 revenue of $496.2 million, with net loss narrowing to $26.6 million. However, adjusted EBITDA declined due to rising medical costs, reflected in a higher medical expense ratio of 93.3%. The company reaffirmed its full-year

Tone
Neutral 50/100
Event
Earnings
Published
07 May 2026 11:10
Source
Stock Titan
Sahm Direct company coverage

Evolent Announces First Quarter 2026 Results

Evolent Health, Inc. announced its financial results for the first quarter ended March 31, 2026, reporting revenue of $496.2 million and a net loss attributable to common shareholders of $26.6 million. Despite a net loss, the company reiterates its full-year 2026 revenue guidance

Tone
Positive 65/100
Event
Earnings
Published
06 May 2026 17:39
Source
Sahm
Sahm Direct company coverage

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

Evolent Health, Inc. (NYSE: EVH) announced that it will release its first quarter 2026 financial results on Thursday, May 7, 2026, before market open. A conference call for shareholders and interested participants will follow at 8 a.m. ET, accessible via Evolent's investor relati

Tone
Neutral 50/100
Event
Earnings
Published
08 Apr 2026 12:40
Source
Sahm
Stock Titan Direct company coverage

[SCHEDULE 13G/A] Evolent Health, Inc. Amended Passive Investment Disclosure

The Vanguard Group filed an Amendment No. 8 to a Schedule 13G/A for Evolent Health, Inc. (EVH), reporting that its beneficial ownership is now 0 shares (0%) due to an internal realignment. This realignment, effective January 12, 2026, means certain Vanguard subsidiaries will now

Tone
Neutral 50/100
Event
Market update
Published
24 Mar 2026 11:41
Source
Stock Titan
Sahm Direct company coverage

Evolent announces appointment of Archie Mayani as chief product officer

Evolent Health, Inc. has announced the appointment of Archie Mayani as Chief Product Officer. Mayani brings over two decades of experience in healthcare technology and AI, having previously held leadership roles at GHX, Change Healthcare, UnitedHealth Group, and Amazon. Her exper

Tone
Positive 71/100
Event
Market update
Published
19 Mar 2026 17:41
Source
Sahm
ChartMill Direct company coverage

EVH Stock Price, Quote & Chart | EVOLENT HEALTH INC - A (NYSE:EVH)

This article provides an overview of Evolent Health Inc. (EVH) stock, including its current price of $2.99, recent performance, and key financial metrics. The company reported Q4 earnings recently, beating EPS expectations but missing revenue, and analysts forecast a significant

Tone
Neutral 50/100
Event
Earnings
Published
12 Mar 2026 23:51
Source
ChartMill